CORREVIO PHARMA CORP
(22026V105)
ファンドの報告 CORREVIO PHARMA CORP 13F提出書類による
| 商号 | 保有株式/元本 | 市場価格 | オプション | 報告期間 | 有効日 |
|---|---|---|---|---|---|
| Westfield Capital Management Company LP | 4,825,255 | $10,423k | Jun 30, 2019 | Aug 13, 2019 | |
| Tamarack Advisers LP | 3,350,000 | $7,437k | Jun 30, 2019 | Aug 12, 2019 | |
| Rock Springs Capital Management LP | 1,200,000 | $2,592k | Jun 30, 2019 | Aug 14, 2019 | |
| Renaissance Technologies LLC | 567,648 | $1,226k | Jun 30, 2019 | Aug 12, 2019 | |
| ARS Investment Partners LLC | 422,123 | $912k | Jun 30, 2019 | Aug 12, 2019 | |
| Prelude Capital Management LLC | 108,112 | $234k | Jun 30, 2019 | Aug 14, 2019 |